BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
0.705
-0.021 (-2.83%)
At close: Nov 6, 2024, 4:00 PM
0.710
+0.005 (0.71%)
After-hours: Nov 6, 2024, 6:57 PM EST

BriaCell Therapeutics Stock Forecast

BCTX's stock price has decreased by -83.6% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 1 analyst with a 12-month price forecast for BCTX stock has a target of 15, which predicts an increase of 2,027.66% from the current stock price of 0.71.

Analyst Consensus: Strong Buy
Target Low Average Median High
Price $15 $15 $15 $15
Change +2027.7% +2027.7% +2027.7% +2027.7%
* Price targets were last updated on Oct 3, 2024.

Analyst Ratings

According to 1 stock analyst, the rating for BCTX is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating May '24Jun '24Jul '24Aug '24Sep '24Oct '24
Strong Buy 111111
Buy 000000
Hold 000000
Sell 000000
Strong Sell 000000
Total 111111

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$15
Strong Buy Reiterates $15 +2,027.66% Oct 3, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Maintains
$18$15
Strong Buy Maintains $18$15 +2,027.66% Sep 19, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$18
Strong Buy Reiterates $18 +2,453.19% Sep 11, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$18
Strong Buy Reiterates $18 +2,453.19% Jun 4, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$18
Strong Buy Reiterates $18 +2,453.19% May 24, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.93
from -0.29
EPS Next Year
-0.39
from -0.93
Fiscal Year FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Jul 31, 2020 Jul 31, 2021 Jul 31, 2022 Jul 31, 2023 Jul 31, 2024 Jul 31, 2025 Jul 31, 2026 Jul 31, 2027
Revenue
-------10.20M
Revenue Growth
--------
EPS
-5.64-3.06-1.73-1.30-0.29-0.93-0.39-0.29
EPS Growth
--------
Forward PE
--------
No. Analysts -----322
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202520262027
High n/a n/a 10.6M
Avg n/a n/a 10.2M
Low n/a n/a 9.9M

Revenue Growth

Revenue Growth 202520262027
High - - -
Avg - - -
Low - - -

EPS Forecast

EPS 202520262027
High -0.61 -0.41 -0.30
Avg -0.93 -0.39 -0.29
Low -1.23 -0.38 -0.28

EPS Growth

EPS Growth 202520262027
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.